A Review of Everything in Its Place: First Loves and Last Tales

This posthumously published collection of essays by Oliver Sacks further cements the neurologist’s place in the pantheon of science writers.

Written byBob Grant
| 3 min read
oliver sacks book everything in its place

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Oliver Sacks has been dead for more than three years. In August 2015, the British neurologist and author succumbed to metastatic cancer, which had started nine years earlier as uveal melanoma, seemingly vanquished at the cost of sight in his right eye. But his vision lives on. In Everything in Its Place, a collection of his essays, Sacks details the joy and despair he experienced in his 82 years of living.

Among popularizers of science, Sacks has always stood out as particularly adept at imbuing his writing with blood, life, and history. His agility with the microscope of prose—zooming in on acute scenes from his own life, then back out to encapsulate life and science as a whole—is in full flourish in his latest book, to be published later this month. For example, in the essay “Humphry Davy: Poet of Chemistry,” he precisely details his boyhood fascination with the renowned ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer. Before joining the team, he worked as a reporter at Audubon and earned a master’s degree in science journalism from New York University. In his previous life, he pursued a career in science, getting a bachelor’s degree in wildlife biology from Montana State University and a master’s degree in marine biology from the College of Charleston in South Carolina. Bob edited Reading Frames and other sections of the magazine.

    View Full Profile

Published In

The Scientist April 2019 Issue
April 2019

Will Car T Cells Smash Tumors?

New trials take the therapy beyond the blood

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies